Clinical Trials Directory

Trials / Completed

CompletedNCT01892150

Histologic Response to UVA and UVB Exposure During the Use of Sunscreen

Histologic Response to UVA and UVB Exposure During the Use of Sunscreen With Anti-inflammatory and Anti-oxidant Properties - A Pilot Study

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
2 (actual)
Sponsor
Mahidol University · Academic / Other
Sex
Female
Age
35 Years – 65 Years
Healthy volunteers
Accepted

Summary

Anti-inflammatory and anti-oxidant agents have become the important ingredients in sunscreen. However, there is no histologic study about the effects of anti-inflammatory and anti-oxidative properties of sunscreen to prevent premature aging from UVA and UVB.

Detailed description

Premature aging can be prevented by using sunscreen. Currently, anti-inflammatory and anti-oxidant agents have become the important ingredients in sunscreen. However, there is no histologic study about the effects of anti-inflammatory and anti-oxidative properties of sunscreen to prevent premature aging from UVA and UVB.

Conditions

Interventions

TypeNameDescription
OTHERSunscreenApply sunscreen before and after UVA and UVB irradiation

Timeline

Start date
2013-03-01
Primary completion
2013-07-01
Completion
2013-07-01
First posted
2013-07-04
Last updated
2014-03-31

Locations

1 site across 1 country: Thailand

Source: ClinicalTrials.gov record NCT01892150. Inclusion in this directory is not an endorsement.

Histologic Response to UVA and UVB Exposure During the Use of Sunscreen (NCT01892150) · Clinical Trials Directory